Previous studies showed that up to one-third of patients with NASH might progress to HCC (26, 27), so we explored the role of six progress-related genes (AKR1B10/SPP1/CD24/UBD/FABP4/STMN2) in HCC. Here, STMN2 is linked to hepatocellular carcinoma.